Czechia· CZ-0250255

LEQVIO

A inclisiran product containing inclisiran sodium, registered in Czechia by Novartis Europharm Limited, Dublin. The same ATC class is registered in 14 of our 19 countries.

ATC C10AX16

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedLEQVIOATCC10AX16REGISTER NO.CZ-0250255PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Inclisiran is registered in 14 of 19 countries.

Countries holding a registration under ATC C10AX16 (inclisiran), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 9 of them publish a price we can compare per daily dose

Inclisiran · ATC C10AX16

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
INCLISIRAN SODIUM
Manufacturer
Novartis Europharm Limited, Dublin
Country
Czechia (CZ)
ATC code
C10AX16
ATC class
Inclisiran
Defined daily dose
1.6 mg, P
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0250255
    1X1,5ML I
    CZK 57154.01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Inclisiran in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All inclisiran products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/93e78431-497a-4420-938b-3099b68451c1
GET /v1/drugs/93e78431-497a-4420-938b-3099b68451c1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ SOL ISP",
  "source": "sukl",
  "strength": "284MG",
  "pack_size": "1X1,5ML I",
  "substance": "INCLISIRAN SODIUM",
  "cz_kod_sukl": "0250255",
  "product_type": null,
  "substance_codes": "22749",
  "registration_state": "R",
  "registration_number": "EU/1/20/1494/001"
}

See everything about inclisiran.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.